This is of relevance for tumor settings, as a healthy cell relies ion PTENS’ ability to modulate GLUT1 levels at the plasma membrane, modulating glucose intake levels and, hence, sustaining its tumor suppressor ability [177]. Here, SLC2A1 is linked to neoplasm.